BIXT Message Board Post 30043980 | Bioxytran Inc
home / stock / bixt / bixt message board
alicenoble32
()
Posted on: Oct/10/2023 15:34:04
$BIXT is reshaping the clinical-stage pharma landscape. With shares at $0.176 and a market cap of $26.32M, they're harnessing Galectin inhibitors for antiviral solutions and diving into the potential of carbohydrate drugs for longevity. Join their mission to redefine healthcare!
News, Short Squeeze, Breakout and More Instantly...
Bioxytran Inc Company Name:
BIXT Stock Symbol:
Market:
-
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
-
AIA Group Limited ADR (AAGIY) is expected to report for Q4 2023 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 SecureWorks Corp. (SCWX) is expected to report $-0.15 for Q4 2024 Acacia Research Corporation (ACTG) is expected to report for quarter end...
-
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...